A carregar...

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence

Evidence from rodent and in vitro models suggests that activation of PPAR-γ by thiazolidinediones (TZDs) causes increased bone marrow adiposity and decreased osteoblastogenesis, resulting in bone loss. TZDs are prescribed for the treatment of diabetes, providing an opportunity to determine whether P...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Schwartz, Ann V.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1779575/
https://ncbi.nlm.nih.gov/pubmed/17259663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/PPAR/2006/24502
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!